INVIVO ANTIOXIDANT POTENTIAL ANALYTES: PROTEINS, VITAMIN C, and GSH OF ALSTONIA BOONEI DE WILD ROOT EXTRACT
Faculty
Department
Year of Publication
Keyword
Publication Type
Abstract
This study evaluates the antioxidant and toxicity profiles of Alstonia boonei aqueous root extract in Wistar rats, a plant widely used in African traditional medicine for its therapeutic properties. Despite its extensive traditional use, limited scientific data exist on its biochemical effects and potential toxicity. This study aims to assess the antioxidant activity and safety profile of Alstonia
boonei to validate its pharmacological relevance. Fourteen Wistar rats were assigned to three groups : a control group and four treatment groups receiving varying doses (100, 250, and 500 mg/kg) of Alstonia boonei root extract for 21 days. Biochemical assays assessed glutathione (GSH), vitamin C levels, total protein concentration, and organ weights. Acute and subacute toxicity studies were conducted, and statistical significance was determined using one-way ANOVA (p ≤ 0.05). No mortality or observable toxicity symptoms were recorded, confirming the extract’s safety at doses up to 5000 mg/kg. A dose-dependent increase in total protein concentration was observed in the liver, reaching 2.60 ± 0.13 g/dL in the 100 mg/kg group (p ≤ 0.05), suggesting enhanced protein synthesis. However, GSH levels declined significantly in the liver from 124.59 ± 2.62 µg/mL (control) to 23.77 ± 0.82 µg/mL (100 mg/kg), indicating a potential transient depletion of antioxidant reserves. Vitamin C levels showed a compensatory increase, peaking at 76.62 ± 27.27 µg/mL in the liver of the 500 mg/kg group. The findings suggest that Alstonia boonei root extract exhibits strong antioxidant potential while maintaining a favorable safety profile. However, the observed depletion of GSH highlights the need for caution in prolonged use. Future research should explore long-term effects, optimal dosage, and molecular mechanisms to ensure its safe application in medicine.
boonei to validate its pharmacological relevance. Fourteen Wistar rats were assigned to three groups : a control group and four treatment groups receiving varying doses (100, 250, and 500 mg/kg) of Alstonia boonei root extract for 21 days. Biochemical assays assessed glutathione (GSH), vitamin C levels, total protein concentration, and organ weights. Acute and subacute toxicity studies were conducted, and statistical significance was determined using one-way ANOVA (p ≤ 0.05). No mortality or observable toxicity symptoms were recorded, confirming the extract’s safety at doses up to 5000 mg/kg. A dose-dependent increase in total protein concentration was observed in the liver, reaching 2.60 ± 0.13 g/dL in the 100 mg/kg group (p ≤ 0.05), suggesting enhanced protein synthesis. However, GSH levels declined significantly in the liver from 124.59 ± 2.62 µg/mL (control) to 23.77 ± 0.82 µg/mL (100 mg/kg), indicating a potential transient depletion of antioxidant reserves. Vitamin C levels showed a compensatory increase, peaking at 76.62 ± 27.27 µg/mL in the liver of the 500 mg/kg group. The findings suggest that Alstonia boonei root extract exhibits strong antioxidant potential while maintaining a favorable safety profile. However, the observed depletion of GSH highlights the need for caution in prolonged use. Future research should explore long-term effects, optimal dosage, and molecular mechanisms to ensure its safe application in medicine.
Supervisor(s)
co-supervisor